Research Article - (2015) Volume 6, Issue 7
Clinical and Laboratory Hematologic Findings in Patients Receiving Repeated-Dose Injectable HPBCD-Diclofenac for Acute Postoperative Pain: Pooled Analysis of Two Randomized Controlled Phase III Clinical Trials
- Tong J Gan1, Neil Singla2, Stephen E Daniels3, Douglas A Hamilton4,5, Peter G Lacouture6,7, Olufunmibi Johnson8, Christian RD Reyes8 and Daniel B Carr4,9*
- 1Department of Anesthesiology, Stony Brook University, Stony Brook, NY 11794, USA
- 2Lotus Clinical Research, LLC, Pasadena, CA 91105, USA
- 3Premier Research, Austin, TX 78705, USA
- 4Javelin Pharmaceuticals, Inc., Cambridge, MA 02140, USA
- 5New Biology Ventures, LLC, San Francisco, CA 94133, USA
- 6Magidom Discovery, LLC, Lindenhurst, IL, 60046, USA
- 7Brown University School of Medicine, Providence, RI, 02912, USA
- 8Hospira, Inc, Lake Forest, IL 60045, USA
- 9Department of Anesthesiology, Tufts Medical Center, Boston, MA 02111, USA
*Corresponding Author:
Daniel B Carr, Department of Anesthesiology, Tufts Medical Center, #298, 800 Washington Street, Boston, MA 02111, USA, Tel: 617-636-9710, Fax: 617-636-9709
Email:
